Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01551459 |
|---|---|
| Brief Title: | A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma (SUAVE) |
| First Submitted : | March 8, 2012 |
| First Submitted that Met QC Criteria : | March 9, 2012 |
| First Posted : | March 12, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 27, 2019 |
| Last Update Posted : | October 29, 2019 |